Poly(ADP-Ribose) polymerase (PARP) inhibitors for locally advanced or metastatic breast cancer
Version 2 2024-06-06, 20:02Version 2 2024-06-06, 20:02
Version 1 2018-07-10, 09:46Version 1 2018-07-10, 09:46
journal contribution
posted on 2024-06-06, 20:02authored byM Khasraw, SM Patil, TA Traina, ME Robson
This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of PARP inhibitors for women with locally advanced or metastatic breast cancer.